clyde r u still with us??, page-32

It is quite possible that MS, DP and Co have been cagey until they had the trial results firmly in hand. After all, the results announced last week effectively put a price on the project, as opposed to just a theoretical range.

Surely the report that was compiled on the malaria treatment market would give the company sufficient information to indicate what the project is worth.
They then give some parameters to AFG regarding type of sale structure and roundabout price levels and its up to AFG to bring big pharma to Eastlands door.